Capillary Blood Collection Devices Market Size, Share and Growth Outlook, 2026

Capillary Blood Collection Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Capillary Blood Collection Devices Market size is forecast to increase from $3.17 Billion in 2026 to $6.5 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

The Capillary Blood Collection Devices market report provides detailed analysis and outlook of Capillary Blood Collection Devices segments including By Product Type (Safety Lancets, Lancing Devices, Capillary Blood Collection Tubes, Microfluidic and Self-Collection Devices, Dried Blood Spot ), By Application (Blood Glucose Testing Focus, Neonatal and Genetic Screening Focus, Infectious Disease Rapid Diagnostic Testing, Comprehensive Metabolic and Liver Panels, Hematology and Coagulation Testing), By Technology (Safety Engineered Retractable Technology, Microfluidic Microsampling Technology, Vacuum-Assisted Suction Systems), By Age Group (Pediatric and Neonatal Patients, Adult Patients, Geriatric Patients), By End-User (Hospitals and Clinics, Diagnostic Centers and Pathology Labs, Home Healthcare Settings) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Capillary Blood Collection Devices Industry Overview

Remote Self-Collection Technologies Expanding Decentralized Diagnostics

The capillary blood collection devices industry is experiencing rapid transformation through the adoption of remote and patient-centric sampling technologies. A major advancement is the launch of the truCOLLECT® Solution by Covaris, a PerkinElmer company. This FDA Class I-listed device enables minimally invasive capillary blood self-collection while stabilizing whole blood directly on the collection device. The technology allows samples to be shipped under ambient conditions, eliminating the need for costly cold-chain logistics while supporting downstream molecular applications such as DNA extraction, genomic analysis, and sequencing. The growing preference for home-based diagnostic testing is driving demand for self-collection platforms that improve accessibility, patient convenience, and operational efficiency. These developments are strengthening the role of capillary blood sampling in precision medicine, molecular diagnostics, and remote healthcare delivery models.

Advanced Collection Devices Bridging the Gap Between Fingerstick and Venous Sampling

Innovation within the capillary blood collection market is increasingly focused on improving sample volume, collection consistency, and clinical utility. Medical device manufacturers have secured updated FDA clearances for advanced push-button capillary blood collection systems designed to obtain samples from the upper arm. These automated devices utilize micro-needle puncture technology combined with vacuum-assisted extraction into integrated micro-tubes, producing up to 500 microliters of high-quality capillary blood. This capability effectively bridges the gap between traditional fingerstick collection and conventional venous blood draws. Larger sample volumes allow broader laboratory testing capabilities while reducing the discomfort associated with venipuncture. The increasing availability of automated upper-arm collection devices is expanding the applicability of capillary sampling across routine diagnostics, chronic disease monitoring, and precision healthcare applications.

Enhanced Sample Quality and POCT Compatibility Supporting Laboratory Integration

Manufacturers are actively improving capillary blood collection systems to support laboratory-grade sample quality and seamless integration with point-of-care testing workflows. SARSTEDT AG & Co. KG has strengthened its market position through updates to its capillary collection tube portfolio, focusing on enhanced compatibility with existing point-of-care testing platforms and streamlined laboratory operations. Simultaneously, major manufacturers have introduced advanced EDTA and lithium heparin coating formulations designed to address one of the industry's most significant challenges: sample rejection caused by hemolysis. Laboratory studies have demonstrated that revised tube coatings and optimized flow-path engineering significantly reduce shear stress during blood collection, lowering cell rupture rates and improving sample integrity. These innovations are helping capillary blood collection devices meet increasingly stringent central laboratory standards while supporting broader adoption in clinical diagnostics.

Decentralized Clinical Trials Driving Home-Based Blood Collection Adoption

The expansion of decentralized clinical research is creating substantial demand for self-administered capillary blood collection devices. Global contract research organizations and pharmaceutical companies have formally incorporated patient-led capillary sampling into decentralized trial protocols. By replacing traditional clinic-based venipuncture with home collection methods, these studies have reported meaningful reductions in patient attrition and improved participant engagement. Validation data further confirm that advanced stabilizing additives incorporated into micro-collection tubes maintain sample integrity for central laboratory testing panels throughout transport and storage. As decentralized healthcare models continue to expand, capillary blood collection technologies are becoming critical tools for enabling remote patient monitoring, virtual clinical trials, and more accessible diagnostic testing programs.

Capillary Blood Collection Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Capillary Blood Collection Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company (BD), Terumo Corporation, Sarstedt AG & Co. KG, Streck, Inc., Greiner Bio-One International GmbH, Kabe Labortechnik GmbH, Improve Medical, Bionostics , Cardinal Health, Inc., Thermo Fisher Scientific Inc.. The Capillary Blood Collection Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Capillary Blood Collection Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Capillary Blood Collection Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Capillary Blood Collection Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Capillary Blood Collection Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Capillary Blood Collection Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Capillary Blood Collection Devices industry include- Becton, Dickinson and Company (BD), Terumo Corporation, Sarstedt AG & Co. KG, Streck, Inc., Greiner Bio-One International GmbH, Kabe Labortechnik GmbH, Improve Medical, Bionostics , Cardinal Health, Inc., Thermo Fisher Scientific Inc.. The Capillary Blood Collection Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Capillary Blood Collection Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Capillary Blood Collection Devices market remains one of the strongest-performing segments in the country.
The US Capillary Blood Collection Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Capillary Blood Collection Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Capillary Blood Collection Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Capillary Blood Collection Devices markets

Canada's strong Capillary Blood Collection Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Capillary Blood Collection Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Capillary Blood Collection Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Capillary Blood Collection Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Capillary Blood Collection Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Capillary Blood Collection Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Capillary Blood Collection Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Capillary Blood Collection Devices sales through 2034

France Capillary Blood Collection Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Capillary Blood Collection Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Capillary Blood Collection Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Capillary Blood Collection Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Capillary Blood Collection Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Capillary Blood Collection Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Capillary Blood Collection Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Capillary Blood Collection Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Capillary Blood Collection Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Capillary Blood Collection Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Capillary Blood Collection Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Capillary Blood Collection Devices Market Segmentation

By Product Type
Safety Lancets
Lancing Devices
Capillary Blood Collection Tubes
Microfluidic and Self-Collection Devices
Dried Blood Spot
By Application
Blood Glucose Testing Focus
Neonatal and Genetic Screening Focus
Infectious Disease Rapid Diagnostic Testing
Comprehensive Metabolic and Liver Panels
Hematology and Coagulation Testing
By Technology
Safety Engineered Retractable Technology
Microfluidic Microsampling Technology
Vacuum-Assisted Suction Systems
By Age Group
Pediatric and Neonatal Patients
Adult Patients
Geriatric Patients
By End-User
Hospitals and Clinics
Diagnostic Centers and Pathology Labs
Home Healthcare Settings

Top Companies in Capillary Blood Collection Devices Industry

Becton, Dickinson and Company (BD)
Terumo Corporation
Sarstedt AG & Co. KG
Streck, Inc.
Greiner Bio-One International GmbH
Kabe Labortechnik GmbH
Improve Medical
Bionostics
Cardinal Health, Inc.
Thermo Fisher Scientific Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025